C4 Therapeutics, Inc.

Quarterly Report for period ending 2023-09-30

Quarterly Report for period ending 2023-06-30

Quarterly Report for period ending 2023-03-31

Annual Report for period ending 2022-12-31

Quarterly Report for period ending 2022-09-30

Quarterly Report for period ending 2022-06-30

Quarterly Report for period ending 2022-03-31

Annual Report for period ending 2021-12-31

Quarterly Report for period ending 2021-09-30

Quarterly Report for period ending 2021-06-30

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Notice of Effectiveness

Annual report to security holders

Post-effective Amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR

Post-effective amendment to a registration statement that is not immediately effective upon filing

Notice of Effectiveness

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Certification by an exchange approving securities for listing

Notice of Effectiveness

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

REYNO LEONARD: Statement of changes in beneficial ownership of securities

Adams Kendra: Statement of changes in beneficial ownership of securities

Hirsch Andrew: Statement of changes in beneficial ownership of securities

Fisher Stewart: Statement of changes in beneficial ownership of securities

Siegel Jolie: Statement of changes in beneficial ownership of securities

Schick Kelly: Statement of changes in beneficial ownership of securities

Boyle Scott N: Statement of changes in beneficial ownership of securities

Hirsch Andrew: Statement of changes in beneficial ownership of securities

RTW INVESTMENTS, LP: Major Shareholders

PRICE T ROWE ASSOCIATES INC /MD/: Major Shareholders

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Automatic shelf registration statement of securities of well-known seasoned issuers

Prospectus filed pursuant to Rule 424(b)(4)

General form of registration statement for all companies including face-amount certificate companies

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Prospectus filed pursuant to Rule 424(b)(4)

A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive proxy statements

Preliminary proxy statement not related to a contested matter or merger/acquisition

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive proxy statements

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive proxy statements